Abstract
BackgroundOne of the next frontiers in HIV research is focused on finding a cure. A new priority includes people with HIV (PWH) with non-AIDS terminal illnesses who are willing to donate their bodies at the end-of-life (EOL) to advance the search towards an HIV cure. We endeavored to understand perceptions of this research and to identify ethical and practical considerations relevant to implementing it.MethodsWe conducted 20 in-depth interviews and 3 virtual focus groups among four types of key stakeholders in the United States (PWH, biomedical HIV cure researchers, HIV clinicians, and bioethicists) to obtain triangulated viewpoints because little was known about the ethics of this topic. Each group was queried as to ethical considerations, safeguards, and protections for conducting HIV cure-related research at the EOL to ensure this research remains acceptable.ResultsAll four key stakeholder groups generally supported HIV cure-related research conducted at the EOL because of the history of altruism within the PWH community and the potential for substantial scientific knowledge to be gained. Our informants expressed that: (1) Strong stakeholder and community involvement are integral to the ethical and effective implementation, as well as the social acceptability of this research; (2) PWH approaching the EOL should not inherently be considered a vulnerable class and their autonomy must be respected when choosing to participate in HIV cure-related research at the EOL; (3) Greater diversity among study participants, as well as multi-disciplinary research teams, is necessitated by HIV cure-related research at the EOL; (4) The sensitive nature of this research warrants robust oversight to ensure a favorable risk/benefit balance and to minimize the possibility of therapeutic misconception or undue influence; and (5) Research protocols should remain flexible to accommodate participants’ comfort and needs at the EOL.ConclusionBecause of the ethical issues presented by HIV cure-related research at the EOL, robust ethical safeguards are of utmost importance. The proposed ethical and practical considerations presented herein is a first step in determining the best way to maximize this research’s impact and social value. More much inquiry will need to be directed towards understanding context-specific and cultural considerations for implementing EOL HIV cure research in diverse settings.
Highlights
Can you please describe your involvement in Human Immunodeficiency Virus (HIV)-related research? Are you familiar with the type of research discussed above? [If yes, move to question
HIV cure-related research at the end of life (Ask for explanation after every answer: Why do you think/feel that way?) What can be done to ensure these types of studies are implemented effectively? What can be done to ensure these types of studies are implemented in an ethical way? What can be done to ensure these studies remain patient/participant-centered? What can be done to ensure these studies remain socially acceptable? How should we navigate the potential conflicts between research aims and clinical care needs? Who should decide? What about advance directives? How do they relate to the priority of the research aims? What about palliative care? How does it relate to the priority of the research aims?
Additional considerations (Ask for explanation after every answer: Why do you think/feel that way?) What should the role of the HIV care provider be in this type of research? Do you think EOL research could be relevant to other fields? Why or why not? Do you think cultural differences play a part in how people view this research? If yes, how so? How do you think COVID-19 might affect perceptions around rapid research autopsy programs? What are the ethical issues brought about by medical-assistance-in-dying– (MAiD) legal in California and Canada?
Summary
Can you please describe your involvement in HIV (cure)-related research? Are you familiar with the type of research discussed above? [If yes, move to question. HIV cure-related research at the end of life (Ask for explanation after every answer: Why do you think/feel that way?) What can be done to ensure these types of studies are implemented effectively? A new priority includes extremely altruistic PWH with non-AIDS terminal illnesses who are willing to donate their bodies at the end-of-life (EOL) to advance the search towards an HIV cure [2, 3]. This type of research is already occurring in the United States and Canada [10, 11] and potentially expanding to other global settings as well
Published Version (Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have